Oropharyngeal Dysphagia Evaluation Tools in Adults with Solid Malignancies Outside the Head and Neck and Upper GI Tract: A Systematic Review

Dysphagia

Volumn 33, Issue 3, 2018, Pages 303-320

  Kenny, Ciarán ^a,b   Gilheaney, Órla ^c   Walsh, Declan ^a,b,d   Regan, Julie ^c  

^a Palliative Medicine   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Assessment; Cancer; Deglutition disorders; Dysphagia; Neoplasms; Quality of life; Swallow screening

Indexed keywords

DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM EXAMINATION; DISEASE ASSOCIATION; DYSPHAGIA; FIBREOPTIC ENDOSCOPIC EVALUATION OF SWALLOWING; HEAD AND NECK CANCER; HUMAN; HYDRATION; MUCOSA INFLAMMATION; NUTRITION; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOLOGICAL WELL-BEING; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; REVIEW; SOLID MALIGNANT NEOPLASM; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL TRACT; VIDEOFLUOROSCOPIC SWALLOWING STUDY; XEROSTOMIA; COMPLICATION; HEAD AND NECK TUMOR; NEOPLASM; PHYSIOLOGY; REPRODUCIBILITY; SWALLOWING;

DEGLUTITION; DEGLUTITION DISORDERS; HEAD AND NECK NEOPLASMS; HUMANS; NEOPLASMS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; UPPER GASTROINTESTINAL TRACT;

EID: 85044628427     PISSN: 0179051X     EISSN: 14320460     Source Type: Journal    
DOI: 10.1007/s00455-018-9892-9     Document Type: Review

References (109)

1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524–48. 10.1001/jamaoncol.2016.5688.
2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544. 10.1016/s0140-6736(16)31012-1.
3. Eisbruch A, Schwartz M, Rasch C, Vineberg K, Damen E, Van As CJ, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–39. 10.1016/j.ijrobp.2004.05.050.
4. Murro D, Jakate S. Radiation esophagitis. Arch Pathol Lab Med. 2015;139(6):827–30. 10.5858/arpa.2014-0111-RS.
5. King SN, Dunlap NE, Tennant PA, Pitts T. Pathophysiology of radiation-induced dysphagia in head and neck cancer. Dysphagia. 2016;31(3):339–51. 10.1007/s00455-016-9710-1.
6. Heijnen BJ, Speyer R, Kertscher B, Cordier R, Koetsenruijter KW, Swan K, Bogaardt H. Dysphagia, speech, voice, and trismus following radiotherapy and/or chemotherapy in patients with head and neck carcinoma: review of the literature. Biomed Res Int. 2016;2016:6086894. 10.1155/2016/6086894.
7. Patterson JM, Hildreth A, McColl E, Carding PN, Hamilton D, Wilson JA. The clinical application of the 100 mL water swallow test in head and neck cancer. Oral Oncol. 2011;47(3):180–4. 10.1016/j.oraloncology.2010.11.020.
8. Carnaby GD, Crary MA. Development and validation of a cancer-specific swallowing assessment tool: mASA-C. Support Care Cancer. 2014;22(3):595–602. 10.1007/s00520-013-2011-4.
9. Belafsky PC, Mouadeb DA, Rees CJ, Pryor JC, Postma GN, Allen J, Leonard RJ. Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919–24.
10. Dwivedi RC, St Rose S, Roe JW, Khan AS, Pepper C, Nutting CM, Clarke PM, Kerawala CJ, Rhys-Evans PH, Harrington KJ, Kazi R. Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral Oncol. 2010;46(4):e10–4. 10.1016/j.oraloncology.2010.02.004.
11. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, de Graeff A, Boysen M, Evensen JF, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire—H&N35. J Clin Oncol. 1999;17(3):1008–19.
12. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson Dysphagia Inventory. Arch Otolaryngol Head Neck Surg. 2001;127(7):870–6.
13. Lagergren P, Fayers P, Conroy T, Stein HJ, Sezer O, Hardwick R, et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-OG25, to assess health-related quality of life in patients with cancer of the oesophagus, the oesophago-gastric junction and the stomach. Eur J Cancer. 2007;43(14):2066–73. 10.1016/j.ejca.2007.07.005.
14. Rinkel RN, Verdonck-de Leeuw IM, Langendijk JA, van Reij EJ, Aaronson NK, Leemans CR. The psychometric and clinical validity of the SWAL-QOL questionnaire in evaluating swallowing problems experienced by patients with oral and oropharyngeal cancer. Oral Oncol. 2009;45(8):e67–71. 10.1016/j.oraloncology.2009.03.003.
15. Garon BR, Sierzant T, Ormiston C. Silent aspiration: results of 2,000 video fluoroscopic evaluations. J Neurosci Nurs. 2009;41(4):178–85.
16. Portenoy RK, Thaler HT, Kornblith AB, Lepore JM, Friedlander-Klar H, Coyle N, et al. Symptom prevalence, characteristics and distress in a cancer population. Qual Life Res. 1994;3(3):183–9.
17. Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT. The Memorial Symptom Assessment Scale Short Form (MSAS-SF). Cancer. 2000;89(5):1162–71.
18. Chiu TY, Hu WY, Chen C-Y. Prevalence and severity of symptoms in terminal cancer patients: a study in Taiwan. Support Care Cancer. 2000;8(4):311–3. 10.1007/s005209900112.
19. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender and performance status in 1,000 patients. Support Care Cancer. 2000;8(3):175–9. 10.1007/s005209900128.
20. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80(5):346–50.
21. Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K. Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. J Pain Symptom Manag. 2003;25(5):420–9. 10.1016/s0885-3924(03)00074-5.
22. Gift AG, Jablonski A, Stommel M, William Given C. Symptom clusters in elderly patients with lung cancer. Oncol Nurs Forum. 2004;31(2):203–12. 10.1188/04.onf.203-212.
23. Teunissen SC, de Graeff A, de Haes HC, Voest EE. Prognostic significance of symptoms of hospitalised advanced cancer patients. Eur J Cancer. 2006;42(15):2510–6. 10.1016/j.ejca.2006.05.025.
24. Tsai JS, Wu CH, Chiu TY, Hu WY, Chen CY. Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med. 2006;20(6):617–22.
25. Kenne Sarenmalm E, Ohlen J, Jonsson T, Gaston-Johansson F. Coping with recurrent breast cancer: predictors of distressing symptoms and health-related quality of life. J Pain Symptom Manag. 2007;34(1):24–39. 10.1016/j.jpainsymman.2006.10.017.
26. Molassiotis A, Wengstrom Y, Kearney N. Symptom cluster patterns during the first year after diagnosis with cancer. J Pain Symptom Manag. 2010;39(5):847–58. 10.1016/j.jpainsymman.2009.09.012.
27. Abu-Saad Huijer H, Abboud S, Doumit M. Symptom prevalence and management of cancer patients in Lebanon. J Pain Symptom Manag. 2012;44(3):386–99. 10.1016/j.jpainsymman.2011.10.019.
28. Stark L, Tofthagen C, Visovsky C, McMillan SC. The symptom experience of patients with cancer. J Hosp Palliat Nurs. 2012;14(1):61–70. 10.1097/NJH.0b013e318236de5c.
29. Ritchie C, Dunn LB, Paul SM, Cooper BA, Skerman H, Merriman JD, et al. Differences in the symptom experience of older oncology outpatients. J Pain Symptom Manag. 2014;47(4):697–709. 10.1016/j.jpainsymman.2013.05.017.
30. Mercadante S, Aielli F, Adile C, Ferrera P, Valle A, Fusco F, et al. Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Support Care Cancer. 2015;23(11):3249–55. 10.1007/s00520-015-2720-y.
31. Brady GC, Roe JWG, O’Brien M, Boaz A, Shaw C. An investigation of the prevalence of swallowing difficulties and impact on quality of life in patients with advanced lung cancer. Support Care Cancer. 2017. 10.1007/s00520-017-3858-6.
32. Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, et al. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Can. 1994;30A(9):1326–36.
33. Uniform Data System for Medical Rehabilitation. The FIM system advantage. Uniform Data System for Medical Rehabilitation. 2016. https://www.udsmr.org/Documents/FIM/FIM_System_SNF.pdf. Accessed 03 Jan 2018.
34. Camidge DR. The causes of dysphagia in carcinoma of the lung. J R Soc Med. 2001;94(11):567–72.
35. Brady GC, Carding PN, Bhosle J, Roe JW. Contemporary management of voice and swallowing disorders in patients with advanced lung cancer. Curr Opin Otolaryngol Head Neck Surg. 2015;23(3):191–6. 10.1097/MOO.0000000000000155.
36. Gross RD, Atwood CW Jr, Ross SB, Olszewski JW, Eichhorn KA. The coordination of breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2009;179(7):559–65. 10.1164/rccm.200807-1139OC.
37. Kirkova J, Rybicki L, Walsh D, Aktas A, Davis MP, Karafa MT. The relationship between symptom prevalence and severity and cancer primary site in 796 patients with advanced cancer. Am J Hosp Palliat Care. 2011;28(5):350–5. 10.1177/1049909110391464.
38. Hui D, dos Santos R, Chisholm GB, Bruera E. Symptom expression in the last seven days of life among cancer patients admitted to acute palliative care units. J Pain Symptom Manag. 2015;50(4):488–94. 10.1016/j.jpainsymman.2014.09.003.
39. Bruera E, Miller MJ, Kuehn N, MacEachern T, Hanson J. Estimate of survival of patients admitted to a palliative care unit: a prospective study. J Pain Symptom Manag. 1992;7(2):82–6.
40. Chuang RB, Hu WY, Chiu TY, Chen CY. Prediction of survival in terminal cancer patients in Taiwan: constructing a prognostic scale. J Pain Symptom Manag. 2004;28(2):115–22. 10.1016/j.jpainsymman.2003.11.008.
41. Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H, et al. Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol. 2010;28(28):4376–83. 10.1200/JCO.2009.27.1916.
42. Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SC. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol. 2012;84(1):130–48. 10.1016/j.critrevonc.2012.02.011.
43. Hui D, dos Santos R, Chisholm G, Bansal S, Silva TB, Kilgore K, et al. Clinical signs of impending death in cancer patients. Oncologist. 2014;19(6):681–7. 10.1634/theoncologist.2013-0457.
44. Cheng KK. Oral mucositis, dysfunction, and distress in patients undergoing cancer therapy. J Clin Nurs. 2007;16(11):2114–21. 10.1111/j.1365-2702.2006.01618.x.
45. Roe JW, Leslie P, Drinnan MJ. Oropharyngeal dysphagia: the experience of patients with non-head and neck cancers receiving specialist palliative care. Pall Med. 2007;21(7):567–74.
46. McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins J, Chignell KA, Logemann JA, Clarke C. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: I. Conceptual foundation and item development. Dysphagia. 2000;15(3):115–21. 10.1007/s004550010012.
47. Foley NC, Martin RE, Salter KL, Teasell RW. A review of the relationship between dysphagia and malnutrition following stroke. J Rehabil Med. 2009;41(9):707–13. 10.2340/16501977-0415.
48. Serra-Prat M, Palomera M, Gomez C, Sar-Shalom D, Saiz A, Montoya JG, Navajas M, Palomera E, Clave P. Oropharyngeal dysphagia as a risk factor for malnutrition and lower respiratory tract infection in independently living older persons: a population-based prospective study. Age Ageing. 2012;41(3):376–81. 10.1093/ageing/afs006.
49. Carrion S, Cabre M, Monteis R, Roca M, Palomera E, Serra-Prat M, Rofes L, Clave P. Oropharyngeal dysphagia is a prevalent risk factor for malnutrition in a cohort of older patients admitted with an acute disease to a general hospital. Clin Nutr. 2015;34(3):436–42. 10.1016/j.clnu.2014.04.014.
50. van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9(Suppl 2):S51–63. 10.1016/j.ejon.2005.09.007.
51. Davies M. Nutritional screening and assessment in cancer-associated malnutrition. Eur J Oncol Nurs. 2005;9(Suppl 2):S64–73. 10.1016/j.ejon.2005.09.005.
52. Thai V, Lau F, Wolch G, Yang J, Quan H, Fassbender K. Impact of infections on the survival of hospitalized advanced cancer patients. J Pain Symptom Manag. 2012;43(3):549–57. 10.1016/j.jpainsymman.2011.04.010.
53. Homsi J, Walsh D, Panta R, Lagman R, Nelson KA, Longworth DL. Infectious complications of advanced cancer. Support Care Cancer. 2000;8(6):487–92.
54. McAllister S, Kruger S, Doeltgen S, Tyler-Boltrek E. Implications of variability in clinical bedside swallowing assessment practices by speech language pathologists. Dysphagia. 2016;31(5):650–62. 10.1007/s00455-016-9724-8.
55. Lucchetta M, Lonardi S, Bergamo F, Alberti P, Velasco R, Argyriou AA, et al. Incidence of atypical acute nerve hyperexcitability symptoms in oxaliplatin-treated patients with colorectal cancer. Cancer Chemother Pharmacol. 2012;70(6):899–902. 10.1007/s00280-012-2006-8.
56. Loh SY, McLeod RWJ, Elhassan HA. Trismus following different treatment modalities for head and neck cancer: a systematic review of subjective measures. Eur Arch Otorhinolaryngol. 2017;274(7):2695–707. 10.1007/s00405-017-4519-6.
57. Thier K, Calabek B, Tinchon A, Grisold W, Oberndorfer S. The last 10 days of patients with glioblastoma: assessment of clinical signs and symptoms as well as treatment. Am J Hosp Palliat Care. 2016;33(10):985–8. 10.1177/1049909115609295.
58. Takizawa C, Gemmell E, Kenworthy J, Speyer R. A systematic review of the prevalence of oropharyngeal dysphagia in stroke, Parkinson’s disease, Alzheimer’s disease, head injury, and pneumonia. Dysphagia. 2016;31(3):434–41. 10.1007/s00455-016-9695-9.
59. Li J, Wang D, Tao W, Dong W, Zhang J, Yang J, Liu M. Early consciousness disorder in acute ischemic stroke: incidence, risk factors and outcome. BMC Neurol. 2016;16(1):140. 10.1186/s12883-016-0666-4.
60. Miles A, McFarlane M, Kainth P, Parmar P. Interdisciplinary management of dysphagia. Nurs Res Care. 2014;16(10):561–7. 10.12968/nrec.2014.16.10.561.
61. University of York. PROSPERO International prospective register of systematic reviews. University of York. 2017. https://www.crd.york.ac.uk/prospero/display_record.asp?ID=CRD42016038235. Accessed 01 March 2018.
62. Veritas Health Innovation. Covidence systematic review software. Veritas Health Innovation. 2017. https://www.covidence.org/. Accessed 01 March 2018.
63. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):1–6. 10.1371/journal.pmed.1000097.
64. Whiting P, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529–36.
65. The Cochrane Collaboration. Review Manager (RevMan) [Computer program], version 5.3 edn. Copenhagen: The Cochrane Collaboration, The Nordic Cochrane Centre; 2014.
66. Clarivate Analytics. EndNote X7. 7.1 edn. Philadelphia: Thomson Reuters; 2014.
67. Higo R, Tayama N, Watanabe T, Nito T. Pulse oximetry monitoring for the evaluation of swallowing function. Eur Arch Otorhinolaryngol. 2003;260(3):124–7. 10.1007/s00405-002-0527-1.
68. Tohara H, Saitoh E, Mays KA, Kuhlemeier K, Palmer JB. Three tests for predicting aspiration without videofluorography. Dysphagia. 2003;18(2):126–34. 10.1007/s00455-002-0095-y.
69. Wang TG, Chang YC, Chen SY, Hsiao TY. Pulse oximetry does not reliably detect aspiration on videofluoroscopic swallowing study. Arch Phys Med Rehabil. 2005;86(4):730–4. 10.1016/j.apmr.2004.10.021.
70. Ding R, Logemann JA. Patient self-perceptions of swallowing difficulties as compared to expert ratings of videofluorographic studies. Folia Phoniatr Logop. 2008;60(3):142–50. 10.1159/000120622.
71. McHorney CA, Robbins J, Lomax K, Rosenbek JC, Chignell K, Kramer AE, Bricker DE. The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: III. Documentation of reliability and validity. Dysphagia. 2002;17(2):97–114. 10.1007/s00455-001-0109-1.
72. Shaw JL, Sharpe S, Dyson SE, Pownall S, Walters S, Saul C, et al. Bronchial auscultation: an effective adjunct to speech and language therapy bedside assessment when detecting dysphagia and aspiration? Dysphagia. 2004;19(4):211–8. 10.1007/s00455-004-0008-3.
73. Ryu JS, Park SR, Choi KH. Prediction of laryngeal aspiration using voice analysis. Am J Phys Med Rehabil. 2004;83(10):753–7. 10.1097/01.phm.0000140798.97706.a5.
74. Miura H, Kariyasu M, Yamasaki K, Arai Y. Evaluation of chewing and swallowing disorders among frail community-dwelling elderly individuals. J Oral Rehabil. 2007;34(6):422–7. 10.1111/j.1365-2842.2007.01741.x.
75. Suiter DM, Leder SB. Clinical utility of the 3-ounce water swallow test. Dysphagia. 2008;23(3):244–50. 10.1007/s00455-007-9127-y.
76. Leder SB, Suiter DM, Green BG. Silent aspiration risk is volume-dependent. Dysphagia. 2011;26(3):304–9. 10.1007/s00455-010-9312-2.
77. González-Fernández M, Sein MT, Palmer JB. Clinical experience using the mann assessment of swallowing ability for identification of patients at risk for aspiration in a mixed-disease population. Am J Speech Lang Pathol. 2011;20(4):331. 10.1044/1058-0360(2011/10-0082).
78. Sato M, Tohara H, Iida T, Wada S, Inoue M, Ueda K. Simplified cough test for screening silent aspiration. Arch Phys Med Rehabil. 2012;93(11):1982–6. 10.1016/j.apmr.2012.05.016.
79. Silbergleit AK, Schultz L, Jacobson BH, Beardsley T, Johnson AF. The dysphagia handicap index: development and validation. Dysphagia. 2012;27(1):46–52. 10.1007/s00455-011-9336-2.
80. Leder SB, Suiter DM, Murray J, Rademaker AW. Can an oral mechanism examination contribute to the assessment of odds of aspiration? Dysphagia. 2013;28(3):370–4. 10.1007/s00455-012-9442-9.
81. Mann G. MASA: the mann assessment of swallowing ability. Clifton Park: Singular/Thomson Learning; 2002.
82. Winchester J, Winchester CG. Cognitive dysphagia and effectively managing the five systems. Perspect Gerontol. 2015;20(3):116–32. 10.1044/gero20.3.116.
83. Pu D, Murry T, Wong MCM, Yiu EML, Chan KMK. Indicators of dysphagia in aged care facilities. J Speech Lang Hear Res. 2017;60(9):2416–26. 10.1044/2017_JSLHR-S-17-0028.
84. Byun YH, Sohn S, Park SH, Chung CK. Cervical spine chondroma compressing spinal cord: a case report and literature review. Korean J Spine. 2015;12(4):275–8. 10.14245/kjs.2015.12.4.275.
85. Peker HO, Celik NC, Cikla U, Baskaya MK. Metastatic prostate adenocarcinoma to intradural foramen magnum. J Surg Case Rep. 2017;11:185. 10.1093/jscr/rjx185.
86. Baruah P, Randall CJ, Burgess A. Unusual presentation of cervical spine metastases to the ENT surgeon. J Laryngol Otol. 2013;127(1):92–5. 10.1017/S0022215112002708.
87. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95. 10.1016/s1470-2045(10)70218-7.
88. Wakabayashi H, Matsushima M, Uwano R, Watanabe N, Oritsu H, Shimizu Y. Skeletal muscle mass is associated with severe dysphagia in cancer patients. J Cachexia Sarcopenia Muscle. 2015;6(4):351–7. 10.1002/jcsm.12052.
89. Maeda K, Akagi J. Sarcopenia is an independent risk factor of dysphagia in hospitalized older people. Geriatr Gerontol Int. 2016;16(4):515–21. 10.1111/ggi.12486.
90. Tabor L, Gaziano J, Watts S, Robison R, Plowman EK. Defining swallowing-related quality of life profiles in individuals with amyotrophic lateral sclerosis. Dysphagia. 2016;31(3):376–82. 10.1007/s00455-015-9686-2.
91. Youssof S, Romero-Clark C, Warner T, Plowman E. Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: psychometric properties of the SWAL-QOL instrument. Muscle Nerve. 2017;56(1):28–35. 10.1002/mus.25441.
92. Gilheaney O, Zgaga L, Harpur I, Sheaf G, Kiefer L, Bechet S, Walshe M. The prevalence of oropharyngeal dysphagia in adults presenting with temporomandibular disorders associated with rheumatoid arthritis: a systematic review and meta-analysis. Dysphagia. 2017. 10.1007/s00455-017-9808-0.
93. Fairchild A, Harris K, Barnes E, Wong R, Lutz S, Bezjak A, Cheung P, Chow E. Palliative thoracic radiotherapy for lung cancer: a systematic review. J Clin Oncol. 2008;26(24):4001–11. 10.1200/JCO.2007.15.3312.
94. Chang EL, Shiu AS, Mendel E, Mathews LA, Mahajan A, Allen PK, et al. Phase I/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure. J Neurosurg Spine. 2007;7(2):151–60.
95. Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, Liu P, Allen PK, Azeem SS, Brown PD, Sharp HJ, Weksberg DC, Cleeland CS, Chang EL. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1–2 trial. Lancet Oncol. 2012;13(4):395–402. 10.1016/s1470-2045(11)70384-9.
96. Sharma M, Bennett EE, Rahmathulla G, Chao ST, Koech HK, Gregory SN, Emch T, Magnelli A, Meola A, Suh JH, Angelov L. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk. Neurosurg Focus. 2017;42(1):E14. 10.3171/2016.10.FOCUS16364.
97. Reilly CM, Bruner DW, Mitchell SA, Minasian LM, Basch E, Dueck AC, Cella D, Reeve BB. A literature synthesis of symptom prevalence and severity in persons receiving active cancer treatment. Support Care Cancer. 2013;21(6):1525–50. 10.1007/s00520-012-1688-0.
98. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napenas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bultzingslowen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010;18(8):1039–60. 10.1007/s00520-010-0827-8.
99. Morita T, Tsunoda J, Inoue S, Chihara S. Contributing factors to physical symptoms in terminally-ill cancer patients. J Pain Symptom Manags. 1999;18(5):338–46.
100. Glare P, Walsh D, Sheehan D. The adverse effects of morphine: a prospective survey of common symptoms during repeated dosing for chronic cancer pain. Am J Hosp Palliat Care. 2006;23(3):229–35.
101. Labianca R, Sarzi-Puttini P, Zuccaro SM, Cherubino P, Vellucci R, Fornasari D. Adverse effects associated with non-opioid and opioid treatment in patients with chronic pain. Clin Drug Investig. 2012;32(Suppl 1):53–63. 10.2165/11630080-000000000-00000.
102. Raber-Durlacher JE, Brennan MT, Verdonck-de Leeuw IM, Gibson RJ, Eilers JG, Waltimo T, et al. Swallowing dysfunction in cancer patients. Support Care Cancer. 2012;20(3):433–43. 10.1007/s00520-011-1342-2.
103. Liedberg B, Öwall B. Masticatory ability in experimentally induced xerostomia. Dysphagia. 1991;6(4):211. 10.1007/BF02493529.
104. Rogus-Pulia NM, Logemann JA. Effects of reduced saliva production on swallowing in patients with Sjogren’s syndrome. Dysphagia. 2011;26(3):295–303. 10.1007/s00455-010-9311-3.
105. Davis MP, Walsh D, Lagman R, Yavuzsen T. Early satiety in cancer patients: a common and important but underrecognized symptom. Support Care Cancer. 2006;14(7):693–8. 10.1007/s00520-005-0015-4.
106. Spotten L, Corish C, Lorton C, Dhuibhir PU, O’Donoghue N, O’Connor B, et al. Subjective taste and smell changes in treatment-naive people with solid tumours. Support Care Cancer. 2016;24(7):3201–8. 10.1007/s00520-016-3133-2.
107. Corner J, Wright D, Hopkinson J, Gunaratnam Y, McDonald JW, Foster C. The research priorities of patients attending UK cancer treatment centres: findings from a modified nominal group study. Br J Cancer. 2007;96(6):875–81. 10.1038/sj.bjc.6603662.
108. Dobrina R, Vianello C, Tenze M, Palese A. Mutual needs and wishes of cancer patients and their family caregivers during the last week of life: a descriptive phenomenological study. J Holist Nurs. 2016;34(1):24–34. 10.1177/0898010115581936.
109. Aktas A, Walsh D, Galang M, O’Donoghue N, Rybicki L, Hullihen B, Schleckman E. Underrecognition of malnutrition in advanced cancer: the role of the dietitian and clinical practice variations. Am J Hosp Palliat Care. 2017;34(6):547–55. 10.1177/1049909116639969.